What is the relationship between biological deposits and the enablement requirement?

The relationship between biological deposits and the enablement requirement is crucial in patent law, particularly for biotechnology inventions. According to MPEP 2406.01, the description of biological material must be sufficient to meet the enablement requirement of 35 U.S.C. 112. The MPEP states: “However, it must be clear from the application as filed that the invention…

Read More

What is the difference between actual reduction to practice and constructive reduction to practice?

Actual reduction to practice and constructive reduction to practice are two distinct concepts in patent law: Actual reduction to practice occurs when an inventor physically creates the invention and demonstrates that it works for its intended purpose. This involves building and testing a working prototype. Constructive reduction to practice is achieved when an inventor files…

Read More

Is an actual reduction to practice required before filing a patent application for biological material?

No, an actual reduction to practice is not a prerequisite for filing a patent application, even for biological materials. The MPEP 2406.02 clearly states: “[T]here is no requirement in the patent law that an actual reduction to practice occur as a condition precedent to filing a patent application.” This means that inventors can file patent…

Read More

What is the significance of ‘month to month’ evidence in proving diligence for patent applications?

The significance of ‘month to month’ evidence in proving diligence for patent applications lies in demonstrating continuous effort towards reduction to practice. According to MPEP 715.07(a): ‘Where the evidence of facts establishing diligence is made out on a day-to-day basis, such a record of facts demonstrating reasonably continuous diligence is sufficient to overcome a reference.’…

Read More

How is diligence evaluated in patent applications?

Diligence in patent applications is evaluated on a case-by-case basis, considering the specific circumstances of each invention. The MPEP states, Diligence must be judged on the basis of the particular facts in each case. This principle was reinforced in the case of In re Steed, where the court emphasized that Although the claimed invention is…

Read More

What types of evidence are acceptable for an affidavit or declaration under 37 CFR 1.131(a)?

An affidavit or declaration under 37 CFR 1.131(a) can include various types of evidence to support the inventor’s prior conception and reduction to practice. According to MPEP 715.07: The evidence may consist of testimony of the inventor in the form of an affidavit or declaration under 37 CFR 1.131(a), documentary evidence, drawings, and models. Acceptable…

Read More

What is the diligence requirement for proving prior invention under 37 CFR 1.131(a)?

The diligence requirement is crucial when establishing prior invention under 37 CFR 1.131(a). MPEP 715.07(a) states: Where conception occurs prior to the date of the reference, but reduction to practice is afterward, it is not enough merely to allege that the inventor or inventors had been diligent. Rather, applicant must show evidence of facts establishing…

Read More

What is the ‘Critical Period’ in patent diligence cases?

What is the ‘Critical Period’ in patent diligence cases? The ‘Critical Period’ in patent diligence cases refers to the time frame between the date of conception and the date of reduction to practice. According to MPEP 715.07(a), this period is crucial for determining whether an inventor has shown reasonable diligence in perfecting their invention. The…

Read More